OSTEOPOROSIS Flashcards
T SCORE INTERPRETATION
NORMAL ≥ -1
OSTEOPENIA -1 TO -2.4
OSTEOPOROSIS ≤ -2.5
RECOMMENDED CALCIUM INTAKE FOR MOST ADULTS
1000 - 1200 MG ELEMENTAL CALCIUM
WHAT IS CONSIDERED VIT D DEFICIENCY
< 30 NG/ML
WHAT IS THE VIT D DOSING FOR DEFICIENCY
DAILY: 125 - 175 MCG (5000 - 7000 IU)
WEEKLY: 1250 MCG (50,000 IU)
HOW MUCH ELEMENTAL CALCIUM IN CALCIUM CARBONATE
40%
HOW MUCH ELEMENTAL CALCIUM IN CALCIUM CITRATE
21%
CRITERIA FOR INITIATING TREATMENT FOR OSTEOPOROSIS
T SCORE ≤ -2.5 IN SPINE, NECK, HIP OR 1/3 RADIUS
OR
PRESENCE OF FRIGILITY FRACTURES, REGARDLESS OF BMD
CIRTERIA FOR INITIATING TREATMENT IN OSTEOPENIA HIGH RISK
LOW BONE DENSITY (T-SCORE BETWEEN -1 AND -2.5)
AND
FRAX SCORE ANY FRACTURE ≥ 20% OR HIP FRACTURE ≥3%
TERIPARATIDE (FORTEO)
ABALOPARATIDE (TYMLOS)
INDICATION
RECOMMENDED FOR VERY HIGH RISK PTS ONLY
RALOXIFENE (EVISTA)
BAZEDOXIFENE/ESTROGEN (DUAVEE)
INDICATION
ALTERNATIVE TO BISPHOSPHONATES IF HIGH RISK OF VERTEBRAL FRACTURE
WHICH BISPHOSPHONATES ARE INJECTABLE
IBANDRONATE (BONIVA)
ZALEDRONIC ACID (RECLAST)
INDICATION FOR IBANDRONATE
OSTEOPOROSIS TREATMENT IN POSTMENOPAUSAL FEMALES
ZALEDRONIC ACID INDICATIONS
- PREVENTION (POST MENO FEMALE)
- TREATMENT (MALES AND POST MENO FEMALE)
- GLUCOCOTICOID INDUCED OSTEOPOROSIS
ALENDRONATE DOSING OPTIONS FOR PREVENTION
DAILY OR WEEKLY
ALENDRONATE DOSING OPTIONS FOR TREATMENT
DAILY OR WEEKLY
